Framework for a National STEMI Program: Consensus document developed by STEMI INDIA, Cardiological Society of India and Association Physicians of India  by Alexander, Thomas et al.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 4 9 7 – 5 0 2
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.elsevier.com/locate/ihjCSI Forum: Consensus Statement
Framework for a National STEMI Program:
Consensus document developed by STEMI INDIA,
Cardiological Society of India and Association
Physicians of IndiaThomas Alexander a,*, Ajit S. Mullasari b, Zuzana Kaifoszova b,
Umesh N. Khot b, Brahmajee Nallamothu b, Rao G.V. Ramana b,
Meenakshi Sharma b, Kala Subramaniam b, Ganesh Veerasekar b,
Suma M. Victor b, Kiran Chand b, P.K. Deb c, K. Venugopal c, H.K. Chopra c,
Santanu Guha c, Amal Kumar Banerjee d, A. Muruganathan Armugamd,
Manotosh Panja d, Gurpreet Singh Wander d
a Senior Consultant and Interventional Cardiologist, STEMI INDIA Writing Group, India
b STEMI INDIA Writing Group, India
cCardiological Society of India (CSI), India
dAssociation of Physicians of India (API), Indiaa r t i c l e i n f o
Article history:
Received 25 May 2015
Accepted 25 May 2015
Available online 12 August 2015
Keywords:
STEMI reperfusion
Systems of care
Framework for a national strategy
a b s t r a c t
The health care burden of ST elevation myocardial infarction (STEMI) in India is enormous.
Yet, many patients with STEMI can seldom avail timely and evidence based reperfusion
treatments. This gap in care is a result of ﬁnancial barriers, limited healthcare infrastructure,
poor knowledge and accessibility of acute medical services for a majority of the population.
Addressing some of these issues, STEMI India, a not-for-proﬁt organization, Cardiological
Society of India (CSI) and Association Physicians of India (API) have developed a protocol of
‘‘systems of care’’ for efﬁcient management of STEMI, with integrated networks of facilities.
Leveraging newly-developed ambulance and emergency medical services, incorporating
recent state insurance schemes for vulnerable populations to broaden access, and combin-
ing innovative, ‘‘state-of-the-art’’ information technology platforms with existing hospital
infrastructure, are the crucial aspects of this system. A pilot program was successfully
employed in the state of Tamilnadu. The purpose of this article is to describe the framework
and methods associated with this programme with an aim to improve delivery of reperfu-
sion therapy for STEMI in India. This programme can serve as model STEMI systems of care
ddle income countries.
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(ACS) patients in the world.1 Patients in India who suffer from
ACS are younger (56.3 years) and have a higher proportion
(>60.6%) of ST-elevation myocardial infarction (STEMI) than
patients in developed countries.1 It is estimated that more
than 3million STEMI occurs every year in India.1 Sincemost of
these patients are poor, less likely to get evidence-based
treatments, and have greater 30-day mortality, reducing
delays in access to hospital care and ensuring provision of
affordable treatments could reduce morbidity and mortality.
This article attempts to lay down a framework for a
National STEMI Program in India. Although this framework is
national in its perspective, implementation will be made by
individual states in conjunction with local communities.
Attempts to run this in units smaller than a state (e.g., a
few hospitals in a town) are fraught with the danger of this
program not being inclusive and a substantial number of
STEMI patients within the same geography being unable to
beneﬁt from this program.
While each state maymake certain modiﬁcations based on
their local needs, infrastructure and medical personnel
availability, the basic framework, based on the experience of
the Tamilnadu Pilot STEMI program, would be the ideal way
forward.
2. Outline1. Why is there a need for a STEMI System of Care in India?
2. Structure of the STEMI System of care
3. Partners
4. Infrastructure requirement
5. Management structure
6. Audit and quality improvement
7. Timelines for implementation3. Why is there a need for a STEMI system of
care in India?Despite all its recent and substantial economic advances,
many people in India remain poor. Over 450 million Indians
currently live at or below the poverty line, earning less thanUS
$1.25 a day.2 Developing countries such as India, therefore,
have many urgent public health needs to address, such as
nutrition, sanitation and housing, as well as childhood
vaccination and other preventive services. On the surface,
these challenges make acute reperfusion therapy in STEMI
patients appear less of a priority, a concern more relevant for
afﬂuent countries and healthcare systems. However, coronary
artery disease (CAD) is a major contributor of death and
disability in India, and its overall prevalence has risen
dramatically over the past two decades.3 Approximately 3–
4% of Indians in rural areas and 8–10% in urban areas have
CAD.3 Moreover, Indians are more likely to develop CAD at
younger ages during an individual's working years, and as a
result, there is an extremely high loss of potentially productiveyears of life in India. Among working-age adults (35–64 years
old), nearly 18 million productive years of life are expected to
be lost from CAD by 2030, a number more than nine times
higher than expected in the USA.4 This pattern of disease has
substantial implications for India's growing workforce and
economy. Another reason for concern is the growth of CAD
among poor and middle-class Indians, when once it was
considered a disease of the wealthy.5 Reasons for this include
the potential relationship between fetal or childhood under
nutrition and the subsequent development of cardiovascular
risk factors; a disproportionate use of tobacco products among
the poor; and less access to preventive services and medical
care when compared with wealthier patients.6–8 Not surpris-
ingly, recent studies suggest that poor patients with CAD in
India appear to be at greater risk of acute presentations of CAD
and have worse outcomes following such events. The most
complete data about contemporary trends in STEMI patients
come from CREATE, a large clinical registry of acute coronary
syndrome patients from 89 large hospitals in 10 regions and
cities across India.9 Among the more than 20 000 patients
enrolled in CREATE, over 60% had STEMI, a proportion that is
substantially higher than in North American and European
registries. STEMI patients also were younger and had a lower
socioeconomic status when compared with non- STEMI
patients. The median time from the onset of symptoms to
hospital arrival was 300 min in STEMI patients, again more
than double the delay reported in developed countries. Finally,
approximately 60% received ﬁbrinolytic therapy and only 8%
underwent percutaneous coronary intervention (PCI) during
their hospitalisation, suggesting substantial room for im-
provement in the use of acute reperfusion therapy.10
All this clearly indicates the urgent need to develop a
system for STEMI care in India.
4. Structure of the STEMI system of careThere are three ways of reperfusion in STEMI. The earliest
studies examined thrombolytics, initially with streptokinase
and subsequently with tissue plasminogen activator (TPA)
and its analogues. A meta-analysis of thrombolytics showed
that this was a good way of reperfusion with improved
outcomes across subsets except in the elderly and those
delayed beyond 12 h of symptom onset.11,12 Subsequently
multiple studies have shown the superiority of primary PCI –
both in terms of efﬁcacy and mortality. USA and Europe have
used this as the basis for developing a STEMI system of care.
Although these systems are effective, they are resource
intensive and this approach pre-supposes the availability of a
fairly evenly distributed cath lab density coupled with a good
emergency medical services (EMS) system and physical
infrastructure for transportation. Data from National Inter-
ventional Council as depicted in Table 1, shows that there is a
steady increase in the number of primary PCI done in India
though the percentage remains the same (Table 1).13 Howev-
er, still only a small minority of STEMI patients receive this
modality of reperfusion.9
Multiple studies have subsequently shown that a strategy
of routine and systematic catheterization, with PCI if
indicated, within 24 h of thrombolysis reduces the rate of
Table 1 – Interventions in Acute MI-Coronary Intervention
data for the year 2012.13
2009 2010 2011 2012
Total no. of primary PCI 5584 14271 20541 21343
% of Total interventions 9.79% 12.15% 13.48% 12.04%
[(Fig._2)TD$FIG]
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of thrombolysis followed by cath only for demonstrable
ischemia – a strategy now called the Pharmaco-invasive
strategy.14 The recent STREAM data15 and the Indian data
from the STEP PAMI study16 showed that the pharmaco-
invasive strategy comparedwell with primary PCI in reducing
overall morbidity and mortality.
Based on this evidence, STEMI India has developed a
strategy of combining primary PCI and the Pharmaco-invasive
strategy of reperfusion to produce a coherent framework for
developing a STEMI system of care suitable for India.17,18 The
recommended timelines for the management of STEMI are
given in Fig. 1.Fig. 2 – Architecture of an ST-elevation myocardial
infarction cluster.1. P[(Fig._1)TD$FIG]
Fig
FMrimary PCI is advocated for patients located close to
catheterization laboratories – mostly patients in urban
areas with short transportation times to hospitals with 24/7
primary PCI capabilities.2. Patients in rural areas, with long transportation times to PCI
capable hospitals, will utilise the Pharmaco-invasive
strategy-of thrombolysis followed by catheterization and
PCI if indicated, within 3–24 h of thrombolysis.
The pilot Kovai Erode Study10 and the subsequent Pilot
Tamilnadu STEMI program19 have shown the feasibility of
combining the two strategies of primary PCI and the
pharmaco-invasive strategy.
The architecture of this system is based on a 'hub' and
'spoke' model as depicted in Fig. 2, with each unit being called
a STEMI cluster. Each cluster is made up of two types of hub
hospitals, Class 'A' and Class 'B' hospitals and two types of
spoke hospitals, Class 'C' and Class 'D' hospitals.
Class A hospital is a hub hospital with 24 h primary PCI
capability. The aim is to perform primary PCI at Class A
hospitals with a door to balloon time of less than 90 min.
Patients transferred from a linked spoke hospital would also
have their catheterization and PCI done here between 3 and
24 h of thrombolysis.
Class B hospital is also a hub hospital, however, the
catheterization laboratory does not function 24/7. Patients
would have primary PCI during regular working hours butmay. 1 – Recommended timelines for management of STEMI.
C – First Medical Center, PHC-Primary HJealth Center.be thrombolysed during other times and then take the
pharmacoinvasive approach with catheterization performed
the next day. Spoke hospitals linked to the Class B hospital will
thrombolyse patients and the transfer them here for further
management.
Class C hospital is a spoke hospital located within 30 min
transportation time of the hub hospital. Patients self-present-
ing to these hospitals will have ECG's done, STEMI conﬁrmed
and then transferred to the hub hospital for primary PCI.
Class D Hospital is a hospital located beyond 30 min
transportation time of a hub hospital where a patient with
STEMI is thrombolysed, stabilised and then transported to the
hub hospital within 3–24 h for catheterization and PCI, if
indicated.
Standardized protocols describing the expected care deliv-
ery for a STEMI patient have been designed. These are
available from STEMI India. Different protocols have been
implemented depending on the setting of care – i.e. emergency
medical services, rural spoke hospitals, and PCI-capable hub
hospitals.
However, the care at each of these locations is largely
standardized to meet best practices. Protocols will be simple
and straightforward to eliminate complexitywhich can lead to
confusion during emergency care situations. Local adoptions
of these standardized protocols will require education of
healthcare providers. Protocols should be translated into local
languages to increase their usefulness to patients and local
healthcare providers but the core essence of the processes
recommended should be maintained.
5. PartnersFor the National STEMI program to be successful there has to
be a clear partnership between the various key stakeholders.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 4 9 7 – 5 0 25001. The state government: Any STEMI program will require the
support and involvement of the government. Social insur-
ance to cover the below poverty line population, ambulance
services and participation of the government hospitals in a
STEMI program is crucial to its success as all these are
controlled and facilitated by the state government. Fur-
thermore, funding for the program will come from the
health budget of each state government. The other
important areas that the State Government, in consultation
with the other stakeholders such as STEMI India, CSI and
API, would be involved in would be as follows:
a. Legislation to accredit STEMI hospitals and prescribe
minimum training, infrastructure and manpower
requirements to handle STEMI patients
b. Legislation for EMS to bypass non STEMI hospitals and
transport patients to STEMI accredited hospitals for
management
c. Regulate new STEMI hospitals so that there is an even
distribution of STEMI hospitals across a geographical
area. This could be similar to the 'certiﬁcate of need'
legislation in theUSA. Thiswould encourage newcentres
in inadequately served areas and discourage allocation
of resources in other areas.2. State wide ambulance network. The GVK EMRI ambulance
service now exists in 15 states and union territories. It has a
state wide presence and is an efﬁcient and tested service. It
is critical that an ambulance system similar to GVK EMRI be
available for inter-hospital transfer.3. Cardiological Society of India (CSI): All the hub hospitals
with catheterization laboratories and a signiﬁcant number
of thrombolytic spokes would have members of the CSI as
the heads of the cardiology or medical departments. Each
state has a state branch of the CSI and their involvement in
the planning, development and running of the state
program will be crucial for its success.4. Association Physicians of India (API): A signiﬁcant propor-
tion of the thrombolytic spoke hospitals are managed by
physicians and not by cardiologists. Involvement of the
state branch of the API is also therefore very essential.5. STEMI India will lead the national program by setting the
national strategy and facilitating its implementation in
different states. The Tamilnadu Pilot STEMI project tools,
e.g., the protocols and manuals have already been devel-
oped and tested; technical knowhow and training programs
are also available and can be used. However these may be
modiﬁed, when required based on local needs, in consulta-
tion with the local state partners.6. Public: Engagement with the public to educate patients
about symptoms of concernwith STEMI and the availability
of these services will need to be considered by states that
begin to roll out these programs.6. Infrastructure requirementsFor the program to be successful, certain basic infrastructure
has to be in place across the state. Each state desirous of
starting a STEMI program is required to be well equipped
before employing a state-wide program.1. Facility and manpower mapping: This is a basic pre-
requisite to estimate the number centres capable of PCI
or thrombolysis. It is also important to have data on the
availability of number of cardiologists/physicians, 24/7
catheterization laboratory, and number of intensive care
beds in each centre.2. Geographicmapping: This is necessary to decide on the size
of each STEMI cluster and plan out the linkages. The
number of spokes assigned to a hub would depend on the
population covered, facilities for primary PCI and number of
cardiologist available at that hub. Smaller hubs would have
less spokes attached to them and would be smaller STEMI
clusters.While it is desirable to have aminimumnumber of
primary PCI in a hospital to qualify as a hub hospital, these
criteria may need to be relaxed in poorly served areas. An
appropriate decision should bemade by the governing body
in each state based on local need and resources.3. STEMI incidence and management data: This is important
information that is required prior to implementing a STEMI
program. A 3–4 month pre-implementation data collection
from the hub and spoke hospitals would help to understand
the current case load and treatment practices. This would
help in planning the program as well as estimating the
resource and manpower allocation requirements for a
program.4. Availability of state-wide health insurance to take care of
the vulnerable sections of the population. This insurance
should take care of thrombolysis, Pharmaco-invasive
management and primary PCI. The 'Tamilnadu compre-
hensive health insurance scheme' can be used as amodel to
cover these basic and necessary services.5. State wide ambulance service. The GVK EMRI Ambulance
system is now available in 15 states of the country. The
ambulance services function as an independent entity in
each state and this is the model that, we believe, should be
replicated.6. Project management team: Each state should develop a
project management team responsible for administering
the state's program on a day-to-day basis. Membership on
the project management team should be multidisciplinary
and will involve physicians, nurses, emergency personnel,
information technology, and others as appropriate for each
state. The project management team is responsible for
program administration, STEMI protocol implementation,
identiﬁcation of local operational challenges, data collec-
tion, and reporting of performance aswell as outcomes. The
project management team also helps adoption of the
program with a particular focus on bringing it to local
population. Thismay involve local outreach into both urban
and rural areas and also communication of the STEMI
protocols and program in local languages. The project
management team serves as the ﬁrst contact for healthcare
providers.7. Management structureThe state wide STEMI program should be run by a governing
body consisting of.
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2. Chief Operating Ofﬁcer (COO) of the state ambulance
services
3. Representative of the state CSI
4. Representative of the state API
5. Insurance agency running the state insurance scheme and
6. STEMI India
7. Public representative
The governing body delegates the operations of the project
to the project management team.
Members of the project management team include the
following: Project director
 Physicians
 Nurses
 STEMI coordinator
 Emergency personnel
 Information technology
 Biomedical engineer
 Data analyst/statisticians8. Audit and quality improvementAll centers participating in the STEMI program need to be
committed to adequate data collection and reporting. Data
collection should ideally be in real-time (i.e. at the time of
patient care) and electronic with rapid transmission to
centralized databases. Timely reporting of aggregate data
should be submitted for review, both at the system level and
also locally at each site of care. All centers should commit to
accuracy of data collection to reﬂect the true nature of the
patient care delivered. Results of data are best used to drive
quality improvements in performance and punitive actions
should be avoided.
A quality improvement (QI) committee may be formed for
each region which would oversee the quality improvement
activities such as conduct of periodic review meetings atable 2 – Timelines for implementation of National STEMI frampredeﬁned intervals to assess the effectiveness of the program
as an ongoing process. The datasets that would be utilized for
the assessment of quality improvement are also to be
predeﬁned and fulﬁll the goals to be achieved through this
program. The overall care, outcomes and any scope for
improvement could be assessed and discussed. Any issues
identiﬁed are to be addressed with suggested corrective action
plans and recommendations.
9. Timelines for implementationImplementation should occur in a systematic, step-wise
fashion with speciﬁc attention to the required steps. Clinical
deployment can occur in a staggered manner with 3–4
clusters initially and gradually more clusters can be added
on to cover the whole state. The suggested timelines for
implementation of a National STEMI framework are given in
Table 2.
10. ConclusionSTEMI management in India evidently require organized
systems of care to improve key processes. This ‘‘systems of
care’’ for STEMI management will create new opportunities to
deliver adequate reperfusion therapies in India by addressing
various clinical, logistical and societal factors. As in other
countries, effective management of STEMI at the community
level in India will require executing proven treatment
protocols along with efﬁcient and rapid inter hospital transfer
within coordinated hospital networks. Encouraged by the
success of these protocols implemented in the state of
Tamilnadu, we propose extension of this program to include
the rest of the country. This approach is particularly
worthwhile as it leverages unique public and private partner-
ships, technological innovation in monitoring devices, an
expanding ambulance system, and novel strategies for
reperfusion therapy and early invasive risk stratiﬁcation. If
successful, this type of network may be extended to other low
and middle-income countries.ework.
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